Work

POSTER: AML-665 Predictors of Outcomes in Patients With MECOM EVI1 Rearranged AML or MDS

Year: 2023

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)00480-9

Authors: Yael Kusne, Alyssa McGary, Katalin Kelemen, Mark Litzow, Aref Al-Kali, James Foran, Talha Badar, Mrinal Patnaik, Abhishek Mangaonkar, Lisa Sproat, Jeanne Palmer, Patricia Greipp, Cecilia Arana Yi

Institutions: Mayo Clinic, Mayo Clinic Hospital, National Institute of Health, Mayo Clinic in Arizona, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: University of Miami, University of Pennsylvania, Johns Hopkins University, Deutsches Krebsforschungszentrum, Augusta University, Fakultní nemocnice Hradec Králové, Catholic University of Korea, Chang Gung Medical Foundation, Universitätsklinikum Heidelberg, Seoul St. Mary's Hospital, Catholic University of Korea, College of Medicine, Catholic University of Korea, Duke Cancer Institute, Daiichi Sankyo Europe

OpenAlex ID: W4386278021

FWCI:

Cites:

Cited by:

Related to: 10